Resource Table.
Unique stem cell line identifier	CRMi001-A-1
Alternative name(s) of stem	SANFi002-A-1
cell line	CRMi001-A-1-CLTA-TQ2
	NCRM-5-CLTA-TQ2
Institution	Sanford Research
Contact information of distributor	Kevin Francis; Kevin.Francis@SanfordHealth.org
Type of cell line	iPSC
Origin	Human
Additional origin info	Age: Fetal
	Sex: Male
	Ethnicity if known: Unknown
Cell Source	Umbilical cord blood derived CD34 + cells
Clonality	Mixed
Method of reprogramming	Episomal vectors: Oct4, Sox2, c-Myc, KLF4, Lin28 SV40 Large T antigen
Genetic Modification	Yes
Type of Modification	Knock-in
Associated disease	N/A
Gene/locus	CLTA/9p13.3
Method of modification	CRISPR/Cas9
Name of transgene or resistance	Tq2 and puromycin resistance gene
Inducible/constitutive system	N/A
Date archived/stock date	05/30/17
Cell line repository/bank	N/A
Ethical approval	The CRMi001-A hiPSC line was obtained from the National Heart, Lung, and Blood Institute iPSC Core in Bethesda, MD. All research involving hiPSCs was approved by the Institutional Biosafety Committee at Sanford Research (approval no. 2015101).